Reduced Angiopoietin-2 as a Predictive Biomarker for Clomiphene Citrate Resistance in Polycystic Ovary Syndrome

BACKGROUND: Even though angiopoeitin-2 and interleukin (IL)-23 are known to be altered in polycystic ovary syndrome (PCOS), their association with clomiphene citrate (CC) resistance has not been studied. AIM: The objective of the study was to investigate whether angiopoietin-2 levels are associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajendiran, Luxmipratha, Nandeesha, Hanumanthappa, Chitra, Thyagaraju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279058/
https://www.ncbi.nlm.nih.gov/pubmed/34316229
http://dx.doi.org/10.4103/jhrs.jhrs_179_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279058/
https://www.ncbi.nlm.nih.gov/pubmed/34316229
http://dx.doi.org/10.4103/jhrs.jhrs_179_20

Ejemplares similares